These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25055960)

  • 1. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease.
    Rahimi F; Bee C; Duval C; Boissy P; Edwards R; Jog M;
    J Parkinsons Dis; 2014; 4(4):617-27. PubMed ID: 25055960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and unplanned walking turns in Parkinson's disease - Effects of dopaminergic medication.
    Conradsson D; Paquette C; Lökk J; Franzén E
    Neuroscience; 2017 Jan; 341():18-26. PubMed ID: 27867059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective Gait and Balance Impairments Relate to Balance Confidence and Perceived Mobility in People With Parkinson Disease.
    Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
    Phys Ther; 2016 Nov; 96(11):1734-1743. PubMed ID: 27149959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
    Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
    Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa influences the regularity of the ankle joint kinematics in individuals with Parkinson's disease.
    Kurz MJ; Hou JG
    J Comput Neurosci; 2010 Feb; 28(1):131-6. PubMed ID: 19823927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
    Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J;
    Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
    Hauser RA; Panisset M; Abbruzzese G; Mancione L; Dronamraju N; Kakarieka A;
    Mov Disord; 2009 Mar; 24(4):541-50. PubMed ID: 19058133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
    Brooks DJ; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
    Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Footstep adjustments used to turn during walking in Parkinson's disease.
    Huxham F; Baker R; Morris ME; Iansek R
    Mov Disord; 2008 Apr; 23(6):817-23. PubMed ID: 18200603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
    Østergaard K; Aa Sunde N
    Mov Disord; 2006 May; 21(5):624-31. PubMed ID: 16283616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor complications in Parkinson's disease: ten year follow-up study.
    López IC; Ruiz PJ; Del Pozo SV; Bernardos VS
    Mov Disord; 2010 Dec; 25(16):2735-9. PubMed ID: 20931632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH; Ha JH; Cho IS; Lee MC
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication status and dual-tasking on turning strategies in Parkinson disease.
    Adamson MB; Gilmore G; Stratton TW; Baktash N; Jog MS
    J Neurol Sci; 2019 Jan; 396():206-212. PubMed ID: 30504066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
    Arnold G; Gasser T; Storch A; Lipp A; Kupsch A; Hundemer HP; Schwarz J
    Arch Gerontol Geriatr; 2005; 41(3):239-53. PubMed ID: 16029905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.